Literature DB >> 34333641

Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper.

Stefano Palomba1.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility; however, whether women with PCOS and spontaneous or drug-induced ovulatory cycles have the same reproductive potential as non-PCOS controls is a matter of debate. In the present opinion paper, the author takes the opportunity to summarize the collective evidence supporting the hypothesis of reduced fertility potential in women with PCOS, regardless of ovulatory status, and speculate that reduced reproductive potential may be caused by altered oocytes, embryo and endometrial competence, and infertility-related co-morbidities as well as an increased risk of pregnancy complications.
© The Author(s) 2021. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  embryo; endometrium; implantation; infertility; miscarriage; oocyte; polycystic ovary syndrome; pregnancy complications; subfertility

Year:  2021        PMID: 34333641     DOI: 10.1093/humrep/deab181

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Systematic review update and meta-analysis of randomized and non-randomized controlled trials of ovarian stimulation versus artificial cycle for endometrial preparation prior to frozen embryo transfer in women with polycystic ovary syndrome.

Authors:  Yingying Zhang; Ling Wu; Tin Chiu Li; Chi Chiu Wang; Tao Zhang; Jacqueline Pui Wah Chung
Journal:  Reprod Biol Endocrinol       Date:  2022-04-02       Impact factor: 5.211

2.  Intrauterine Perfusion of Autologous Platelet-Rich Plasma Before Frozen-Thawed Embryo Transfer Improves the Clinical Pregnancy Rate of Women With Recurrent Implantation Failure.

Authors:  Yangying Xu; Cuifang Hao; Jianye Fang; Xiaoqiang Liu; Pingping Xue; Ruichao Miao
Journal:  Front Med (Lausanne)       Date:  2022-03-29

3.  Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies.

Authors:  Sylvia Kiconco; Chau Thien Tay; Kate Louise Rassie; Ricardo Azziz; Helena J Teede; Anju E Joham
Journal:  Hum Reprod       Date:  2022-05-30       Impact factor: 6.353

4.  Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Caiyi Long; Haoyue Feng; Wen Duan; Xin Chen; Yuemeng Zhao; Ying Lan; Rensong Yue
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

5.  Development and validation of a prediction model for depression in adolescents with polycystic ovary syndrome: A study protocol.

Authors:  Rui Ding; Heng Zhou; Xin Yan; Ying Liu; Yunmei Guo; Huiwen Tan; Xueting Wang; Yousha Wang; Lianhong Wang
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

Review 6.  Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility.

Authors:  Piotr Przybycień; Danuta Gąsior-Perczak; Wojciech Placha
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

7.  The Optimal Number of Oocytes Retrieved From PCOS Patients Receiving IVF to Obtain Associated With Maximum Cumulative Live Birth Rate and Live Birth After Fresh Embryo Transfer.

Authors:  Rui Jia; Yuanyuan Liu; Rulan Jiang; Xuli Zhu; Liang Zhou; Peipei Chen; Mingya Cao; Zhiming Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

8.  Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.

Authors:  Jiaqi Zhang; Chuan Xing; Xiangyi Cheng; Bing He
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

9.  Perfluorooctane Sulfonate Induces Dysfunction of Human Umbilical Vein Endothelial Cells via Ferroptosis Pathway.

Authors:  Jiajing Cui; Pingwei Wang; Shuqi Yan; Yujun Liang; Dongge Liu; Shuping Ren
Journal:  Toxics       Date:  2022-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.